AstraZeneca Invests $2 Billion in Summit Therapeutics for Cancer Drug Development
The pharmaceutical giant will jointly develop drugs with the cancer drugmaker following a strategic equity investment.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Summit Therapeutics
- AstraZeneca